Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.405 USD | -1.67% | -5.07% | -29.40% |
Mar. 18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, vs. Street Est of $11.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.40% | 24.63M | |
-11.79% | 87.46B | |
+11.71% | 78.56B | |
+10.85% | 29.37B | |
-11.88% | 16.78B | |
-4.13% | 16.01B | |
-7.22% | 13.98B | |
+1.25% | 12.31B | |
-30.35% | 12.07B | |
+22.01% | 11.06B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen, Queen Mary University to Collaborate on Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection